OSTEONIC Co., Ltd. (KOSDAQ:226400)
South Korea · Delayed Price · Currency is KRW 6,570.00
-100.00 (-1.50%)
At close: Apr 2, 2026
OSTEONIC Revenue
In the year 2025, OSTEONIC had annual revenue of 45.39B KRW with 32.59% growth. OSTEONIC had revenue of 13.01B in the quarter ending December 31, 2025, with 33.69% growth.
Revenue
45.39B
Revenue Growth
+32.59%
P/S Ratio
2.90
Revenue / Employee
236.42M
Employees
192
Market Cap
131.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.39B | 11.16B | 32.59% |
| Dec 31, 2024 | 34.23B | 6.44B | 23.15% |
| Dec 31, 2023 | 27.80B | 7.96B | 40.12% |
| Dec 31, 2022 | 19.84B | 4.24B | 27.19% |
| Dec 31, 2021 | 15.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 135.41B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 63.66B |
| CG MedTech | 47.23B |
| DuChemBIO | 38.57B |
| Wonbiogen | 34.38B |
| Billions | 25.31B |
| SCL Science | 16.32B |